天然咖啡酸衍生物octyl caffeate抑制內毒素/干擾素引發平滑肌細胞產生誘導型一氧化氮合成酵素之機轉探討

Mechanisms of octyl caffeate involved in the inhibition of LPS/interferon-g-induced iNO synthase expression in rat aortic smooth muscle cells

張文瓊(Wen-Chiung Chang)

指導教授 ： 許準榕

臺北醫學大學/醫學院/醫學科學研究所/碩士(2000年)

摘要

中文摘要 在各種發炎疾病狀態下一氧化氮 (nitric oxide；NO) 是一個重要調節及作用的分子。組織在發炎時，大量的NO會藉由誘導型一氧化氮合成酵素 (inducible nitric oxide synthase；iNOS) 產生。尤其在內毒素所引起敗血性休克時，iNOS產生過量的NO被認為是導致低血壓，低反應性血管收縮及組織氧化性傷害的主要原因之一。 本篇論文主要探討，抗氧化強度為 a-tocopherol 7倍之octyl caffeate對於脂多醣體 (LPS) 及干擾素-g (IFN-g) 在大鼠動脈平滑肌細胞產生iNOS的影響，且進一步探討這其中所牽涉的抑制機制。在老鼠動脈平滑肌細胞中，我們發現單以IFN-g (100 U/ml) 處理細胞，無法使平滑肌細胞釋放NO，然而LPS (100 mg/ml) 能明顯誘導NO的產生。若同時將平滑肌細胞投予LPS及IFN-g 則會隨著濃度和時間的增加而明顯提高NO之釋出。當平滑肌細胞於LPS (100 mg/ml) 和IFN-g (100 U/ml) 合併處理24小時後，在培養液中可測得之NO含量約增加為未加藥組的8倍。以不同濃度的octyl caffeate處理後，平滑肌細胞會明顯有意義且以劑量方式減少LPS及IFN-g 誘發產生的NO。 除此之外，事先投予octyl caffeate (1、10 and 50 mM) 30分鐘後，再以LPS及IFN-g 處理24小時，也會隨劑量增加而抑制iNOS mRNA及iNOS protein的表現量。同時，以高濃度 50 mM之octyl caffeate處理平滑肌細胞24小時，並不影響細胞的存活。實驗更進一步發現octyl caffeate並不影響IkB-a 的降解作用，但卻會抑制同屬MAPK成員的JNK/SAPK及ERK1/2這兩個蛋白質的磷酸化。 綜合以上的發現，我們推測octyl caffeate為一強抗氧化劑，其抑制LPS及IFN-g 誘發初代大鼠動脈平滑肌細胞釋放NO的作用機轉可能是透過減少JNK及ERK1/2的活化，接著抑制iNOS mRNA表現，最後導致iNOS protein減少，進而減少NO的累積。這個結果提供了octyl caffeate抑制平滑肌細胞iNOS之作用機轉。因此未來可能利用octyl caffeate抑制iNOS的作用來治療敗血症引發的心血管系統發炎性傷害。

關鍵字

咖啡酸辛酯 ； 內毒素 ； 干擾素 ； 誘導型一氧化氮合成酵素 ； 平滑肌細胞

並列摘要

英文摘要 (Abstract) Nitric oxide (NO) is an important regulator and effector molecule in various inflammatory disease states. High output of NO during inflammation is generated by the inducible isoform of nitric oxide synthase (iNOS). Overproduction of NO by iNOS is thought to be the principal factor of hypotension and hyporeactivity to vasoconstrictor agents observed in endotoxic shock. The present study was to investigate the effect of potent antioxidant, octyl caffeate, on the induction of iNOS formation by lipopolysaccharide (LPS) and interferon-g (IFN-g) in cultured rat aortic smooth muscle cells (RASMC). According to our study, in primary RASMC cultures, IFN-g (100 U/ml) alone did not stimulate NO production, while LPS (100 mg/ml) did. And IFN-g combined with LPS could dose-dependently (LPS: 30, 50, 100 mM) and time-dependently (4 - 24 hr) induce NO production. LPS (100 mg/ml) and IFN-g (100 U/ml) synergistically induced a 8-fold production of NO on RASMC for 24 hrs incubation. Octyl caffeate caused a significant and concentration-dependent inhibition on the production of NO upon stimulation by LPS (100 mg/ml) and IFN-g (100 U/ml) in RASMC. In addition, RASMC pretreated with octyl caffeate (1, 10, 50 mM) by stimulation of LPS/IFN-g caused a concentration-dependent reduction both in iNOS mRNA and protein expression. At the same dose, octyl caffeate did not significantly reduced the cell viability. Furthermore, we found that octyl caffeate did not inhibit IkB-a degradation. In addition, octyl caffeate (10 and 50 mM) significantly inhibited JNK/SAPK and ERK1/2 phosphorylated activation. Therefore, based on the above observations, we suggested that antioxidant, octyl caffeate diminished LPS/IFN-g-induced NO production in RASMC by a mechanism involving inhibition of MAPK activation, followed by the inhibition of iNOS mRNA, thereby leading to the inhibition of iNOS protein and NO production. These results suggest a possible role of octyl caffeate in managing septic inflammation of cardiovascular system through inhibition of iNOS induction.

並列關鍵字

octyl caffeate ； LPS ； interferon ； iNO synthase ； smooth muscle cell

參考文獻

J., Grant, S.K., Wolfe, G., Bach, T.J., Macintyre, D.E. and Hutcuinson, N.I. Lipopolysaccharide-induced hypotension and vascular hyporeactivity in the rat: tissue analysis of nitric oxide synthase mRNA and protein expression in the presence and absence of dexamethasone, NG-monomethyl-L-arginine or indomethacin. J. Pharmacol. Exp. Ther. 272: 452-459, 1995 Ignarro, L.

參考文獻 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20: 865-874, 1992 Baeuerle, P.

A. and Henkel, T. Function and activation of NF-kB in the immune system. Ann. Rev. Immunol. 12: 141-179, 1994 Baldwin, A.

S. The NF-kB and IkB proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-681, 1996 Beasley, D., Cohen, R.

A. and Levinsky, N.G. Interleukin-1 inhabits contraction of vascular smooth muscle. J. Clin. Invest. 83: 331-335, 1989 Beasley, D., Schwarts, J.